{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:20:18Z","timestamp":1771039218002,"version":"3.50.1"},"reference-count":60,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T00:00:00Z","timestamp":1462752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Use of selective serotonin reuptake inhibitors (SSRIs) in late pregnancy has been associated with persistent pulmonary hypertension of the newborn (PPHN), a rare condition with substantial infant mortality and morbidity. Although the increase in absolute risk is small on a population level, it may be of concern to many patients. It remains unclear the extent to which the increased risks reported for PPHN are explained by the underlying maternal illness rather than the use of SSRIs.<\/jats:p>","DOI":"10.1002\/cpt.376","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T14:57:05Z","timestamp":1460300225000},"page":"34-41","source":"Crossref","is-referenced-by-count":17,"title":["Maternal use of selective serotonin\u2010reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn"],"prefix":"10.1111","volume":"100","author":[{"given":"S","family":"Alwan","sequence":"first","affiliation":[{"name":"Department of Medical Genetics University of British Columbia Vancouver Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bandoli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics School of Medicine, University of California, San Diego La Jolla California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CD","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics School of Medicine, University of California, San Diego La Jolla California USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,9]]},"reference":[{"key":"e_1_2_6_1_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2013.00023"},{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2009.04.004"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2005.02.003"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2008.01065.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200608030-00004"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-3037"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39405.539282.BE"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262507"},{"key":"e_1_2_6_9_1","first-page":"696","article-title":"Persistent pulmonary hypertension: assessment of perinatal risk factors","volume":"70","author":"Reece E.A.","year":"1987","journal-title":"Obstet. Gynecol."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5605"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291709992194"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2012.12.005"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.97.5.658","article-title":"Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy","volume":"97","author":"Marter L.J.","year":"1996","journal-title":"Pediatrics"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0496"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.3.519"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010373928"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.07.036"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2012.12.010"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052744"},{"key":"e_1_2_6_20_1","unstructured":"US Food and Drug Administration.Public health advisory: treatment challenges of depression in pregnancy and the possibility of persistent pulmonary hypertension in newborns. <http:\/\/wwwfdagov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm124348htm>"},{"key":"e_1_2_6_21_1","unstructured":"Archive\u2014Newer antidepressants linked to serious lung disorder in newborns 2013. <http:\/\/www.healthycanadians.gc.ca\/recall\u2010alert\u2010rappel\u2010avis\/hc\u2010sc\/2006\/13080a\u2010eng.php>."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1710"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.4065\/84.1.23"},{"key":"e_1_2_6_24_1","unstructured":"US Food and Drug Administration.FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies. <http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm283375.htm> (2012)."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.2165\/11630310-000000000-00000"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11040553"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f6932"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351402"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199901000-00008"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc060602"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1570"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8012"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1021-8"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-163OC"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2012.01.004"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1462"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.11.1129"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.898"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.4.312"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.139"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00132-9"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4002007"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.infbeh.2006.03.003"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036172"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-200109000-00017"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.111"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e31816f2709"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2013.09.001"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01518.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10039"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10048"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.5.499"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.14"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.12.2055"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.02.019"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0817"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000187302.61812.53"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00877-5"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.5.993"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.2.173"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.376","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:34:19Z","timestamp":1699364059000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,9]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1002\/cpt.376"],"URL":"https:\/\/doi.org\/10.1002\/cpt.376","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,9]]}}}